Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Statistics

Total Valuation

OSL:NYKD has a market cap or net worth of NOK 561.66 million. The enterprise value is -521.42 million.

Market Cap	561.66M
Enterprise Value	-521.42M

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	May 27, 2025

Share Statistics

OSL:NYKD has 326.55 million shares outstanding. The number of shares has increased by 5.17% in one year.

Current Share Class	326.55M
Shares Outstanding	326.55M
Shares Change (YoY)	+5.17%
Shares Change (QoQ)	-3.33%
Owned by Insiders (%)	15.96%
Owned by Institutions (%)	30.58%
Float	149.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.45
PB Ratio	0.40
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.96
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1.04

Financial Position

The company has a current ratio of 16.92, with a Debt / Equity ratio of 0.02.

Current Ratio	16.92
Quick Ratio	16.92
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-244.06

Financial Efficiency

Return on equity (ROE) is -17.30% and return on invested capital (ROIC) is -16.72%.

Return on Equity (ROE)	-17.30%
Return on Assets (ROA)	-14.87%
Return on Invested Capital (ROIC)	-16.72%
Return on Capital Employed (ROCE)	-28.72%
Revenue Per Employee	1.16M
Profits Per Employee	-3.55M
Employee Count	136
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.74% in the last 52 weeks. The beta is 1.17, so OSL:NYKD's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	-88.74%
50-Day Moving Average	2.33
200-Day Moving Average	3.36
Relative Strength Index (RSI)	30.86
Average Volume (20 Days)	1,360,424

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:NYKD had revenue of NOK 87.09 million and -266.37 million in losses. Loss per share was -0.83.

Revenue	87.09M
Gross Profit	87.09M
Operating Income	-423.63M
Pretax Income	-342.54M
Net Income	-266.37M
EBITDA	-415.84M
EBIT	-423.63M
Loss Per Share	-0.83

Balance Sheet

The company has 1.12 billion in cash and 34.48 million in debt, giving a net cash position of 1.08 billion or 3.32 per share.

Cash & Cash Equivalents	1.12B
Total Debt	34.48M
Net Cash	1.08B
Net Cash Per Share	3.32
Equity (Book Value)	1.41B
Book Value Per Share	4.32
Working Capital	1.08B

Cash Flow

In the last 12 months, operating cash flow was -501.11 million and capital expenditures -936,268, giving a free cash flow of -502.05 million.

Operating Cash Flow	-501.11M
Capital Expenditures	-936,268
Free Cash Flow	-502.05M
FCF Per Share	-1.54

Margins

Gross Margin	100.00%
Operating Margin	-486.41%
Pretax Margin	-393.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 58.07%.

Dividend Per Share	1.00
Dividend Yield	58.07%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.17%
Shareholder Yield	52.90%
Earnings Yield	-47.43%
FCF Yield	-89.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 7, 2020. It was a forward split with a ratio of 5.

Last Split Date	Jul 7, 2020
Split Type	Forward
Split Ratio	5

Scores

OSL:NYKD has an Altman Z-Score of 10.76.

Altman Z-Score	10.76
Piotroski F-Score	n/a